A new publication involving vasoactive intestinal peptide was released on October 1, 2026. The study, titled "Influence of exogenous glucagon-like peptide 2 on mechanisms of enteric neurotransmitter-mediated vasorelaxation in the isolated bovine mesenteric artery and vein," appeared in the journal Physiological Reports.
The publication is indexed under PubMed ID 42855814. It addresses enteric neurotransmitter-mediated vasorelaxation mechanisms in isolated bovine mesenteric artery and vein tissue, in the context of exogenous glucagon-like peptide 2 exposure. Vasoactive intestinal peptide is referenced as part of the broader neurotransmitter mechanisms under study.
This brief reports only the existence and bibliographic details of the publication as provided. No findings, conclusions, or data from the study are summarized here. Readers seeking the specific results, methodology, or conclusions should consult the full text directly through the source link.
Vasoactive intestinal peptide carries approved regulatory status. Interested readers can review the compound overview page for additional background and context on this peptide.